LUNG TRANSPLANTATION - ADULT (LTX) -> LTX - Immunosuppression, Therapeutics and Pharmacology Abstracts

382 - Intra-Operative Amiodarone-Releasing Hydrogel to Prevent Post Lung Transplant Atrial Fibrillation: A Pilot Clinical Trial

Presentation Number
382
Speakers
Session Name
MINI ORAL 04 - MINI ORAL SESSION: Patient Evaluation and Outcomes Post Lung Transplantation
Date
Wed, Apr 22, 2020
Time
06:15 PM - 07:15 PM
Authors

Previous ePresentation
380 - Current International State of Remote Monitoring Ventricular Assist Device Patients

Next ePresentations
394 - Post-Cardiac Transplant Lymphocytic Thyroiditis Secondary to Amiodarone Use in the Pre-Transplant Period
403 - Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension Risk Stratified by a Dedicated Heart Team to Receive Pulmonary Endarectomy or Balloon Pulmonary Angiogiplasty
414 - More Money and More Miles: The Hidden Costs of Donor Procurement with the New Heart Allocation System
416 - Impact of New UNOS Allocation Criteria on Transplant Practices and Outcomes
417 - Construction and Evaluation of a Bio-Engineered Pump to Enable Subpulmonary Support of the Fontan Circulation: A Proof-of-Concept Study
420 - Yin and Yang of MCS-Related Coagulopathy: Shear Stress Promotes Platelet Prothrombosis and Microparticle Generation While Inducing Integrin Downregulation and Decreased Aggregability
429 - Defining LVAD Success: A Nationwide Survey of LVAD Program Team Members
430 - Risk Score for Mortality Prediction after One-Year on Left Ventricular Assist Device Support
436 - Increased Morbidity and Mortality with Concomitant Aortic Valve Surgery in Patients Receiving a Continuous-Flow Left Ventricular Assist, an IMACS Database Analysis
437 - First Long-Term 5-years Experience with the HeartMate 3 LVAS in Multicentric Clinical Trial